Article info
PDFImage of the moment
Reversible splenial lesion syndrome
- Correspondence to Tamara B Kaplan, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA; tbkaplan{at}partners.org
Citation
Reversible splenial lesion syndrome
Publication history
- Accepted August 20, 2015
- First published September 14, 2015.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Diagnosis and management of Marchiafava–Bignami disease: a review of CT/MRI confirmed cases
- Acute Marchiafava-Bignami disease: clinical and serial MRI correlation
- Mild encephalopathy with reversible splenial lesion in a patient with influenza A infection—first report in an adult patient in the USA
- Evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) by diffusion-weighted and diffusion tensor imaging
- An MRI review of acquired corpus callosum lesions
- Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis
- Infectious encephalitis: mimics and chameleons
- Reversible corpus callosum lesion in legionnaires’ disease
- Cortical abnormalities on MRI: what a neurologist should know
- Marchiafava-Bignami disease presenting as reversible coma